SlideShare une entreprise Scribd logo
1  sur  20
Télécharger pour lire hors ligne
Shashank Sridhara
University of Florida
College of Pharmacy
Doctor of Pharmacy Candidate 2014
Our Patient
 33 y.o Caucasian Female
 PMH- Type 2 Diabetes* & Hypertension
 S Hx- Stopped smoking a few months ago and no EtOH use
 F Hx- Noncontributory
 CC- Pulmonary Sx, Productive cough, SOB, fever and
subjective chills.
 2-3 weeks before being admitted Pt’s mother had a Sinus
infection or a URTI.
 2 weeks prior Pt was in ED and was treated for Pneumonia.
 Patient received Amoxicillin as an inpatient and completed a
course of Ciprofloxacin along with steroids as an outpatient.
 Pt remains symptomatic and is now admitted
Our Patient Physical examination
 VITAL SIGNS: She did have a temperature of 100.1, currently
afebrile.
 She is 93% on room air.
 HEENT: Oral cavity clear.
 CHEST: Clear to auscultation bilaterally.
 CARDIOVASCULAR: S1 and S2 heard. Regular rate and
rhythm.
 ABDOMEN: Soft, nontender.
 EXTREMITIES: No edema.
 MUSCULOSKELETAL: No joint swelling.
 SKIN: No obvious rashes.
Our Patient Lab Data 1
 Her D-dimer (to rule out thrombosis) was negative at 0.47.
 Na is 132 (135 - 147 mEq/L )
 K is 4.1 (3.5 - 5.2 mEq/L )
 BUN of 10 ( 7 - 20 mg/dl)
 Creatinine- 0.6 (0.5 - 1.4 mg/dl)
 Lactic acid is 2.8 (0.7 - 2.1 meq/L)
 White count is 9 (4.5-10 x10^3)
 Hematocrit is 42.9 (41-50%)
 Platelets of 312,000. (100,000 to 450,000)
 Her chest x-ray shows a worsening right-sided and also now left-
sided infiltrate.
 A CT scan has been ordered
 Blood cultures are pending
Patient Meds Pre Admission
•Glipizide 5 mg BID
•Metoprolol 100mg BID
•Lisinopril/Hctz 40/12.5 BID
•Clonidine 0.1mg BID
•Metformin 500mg BID
•Ibuprofen 800mg PRN/TID
Potential Interactions with Abx & Home
meds
 Ran an interaction check with Home meds & Possible Tx
options (Levaquin, Avelox, Cipro, Amoxicillin and
Azithromycin)
 Many PD and PK interactions
 Most of the interactions were minor and none of them
were major or contraindicated.
 Increased effects of metformin and glipizide were the
most concerning of the minor interactions.
 Azithromycin and moxifloxacin both increase the QTc
interval. Significant - Monitor Closely.
CAP- community acquired pneumonia
 Common Typical Pathogens
 S.pneumoniae
 H.influenzaei
 Viral
 Oral anaerobes (Aspiration)
CAP Treatment Options
Complicated (Atypical) Pneumonia
 Atypical pneumonia aka walking pneumonia
 Not caused by traditional pathogens
 Clinical presentation contrasts typical
 These atypical organisms include special bacteria, viruses,
fungi, and protozoa
 Usually will not respond to Beta Lactams and
Sulfonamide class of Abx
Complicated (Atypical) Pneumonia
Signs/Sx
 No signs and symptoms of lobar consolidation,[ meaning that
the infection is restricted to small areas, rather than involving a
whole lobe. As the disease progresses, however, the look can
tend to lobar pneumonia (noted in our patient)
 Absence of leukocytosis (noted in our patient)
 Moderate amount of sputum, or no sputum at all (i.e. non-
productive).
 Lack of alveolar exudate.
 Despite general Sx and problems with the URT (such as high
fever, headache, a dry irritating cough followed later by a
productive cough with radiographs showing
consolidation), there are in general few physical signs. The
patient looks better than the symptoms suggest.
Complicated Pneumonia Pathogens
 Most common causative organisms are
(often intracellular living) bacteria.
 Chlamydophilia Pnemoniae
 Legionella Pneumphila
 Mycoplasma Pneumoniae
 Viral causes
 Respiratory Synctial Virus(RSV),
 Influenza A and B
Diagnosis
 Chest X-rays are gold standard for diagnosis.
 They show a pulmonary infection before physical signs of
atypical pneumonia are observable at all.
 Infiltration commonly occurs near the where the bronchus
begins and tends to be more bilateral .The process most
often involves the lower lobe, but may affect any lobe or
combination of lobes.
Chest X-Rays of Atypical vs Typical
Strep (typical) is more unilateralAtypical is more bilateral
SPECTRUM OF ACTIVITY
Assessment and Plan 1
1. Complicated pneumonia potentially atypical. We will admit for
Brevard
 Pulmonary consultation. We will check blood cultures and other
cultures.
 Zosyn and Azithromycin initiated.
 Rule out for influenza with nasal swab.
 Check a CT scan just to rule out any more complicated infection.
2. Diabetes.
Continue her on sliding scale insulin and carb-controlleddiet.
3. Hypertension.
Continue on her home medications and follow her course expectantly.
Global Rph Empiric Tx Abx site
http://www.globalrph.com/antibiotic.htm
Lab data 2
 White count is 9.79
 Platelets 275,000
 Neutrophils 64.1.
 Blood cultures are negative so far.
 Her chest x-ray does show pneumonia of the right lung, which
apparently has worsened from previous x-ray.
 She did have a CT chest, which showed right upper and middle
lobe pneumonia 2 days ago. Her last x-ray was 13 days ago at
that point, she had right lower lobe infiltrate and the current CT
chest, actually showing right upper and middle lobe infiltrates.
Assessment and plan 2
 This is a very young woman who has now presented with pneumonia.
 Concerned about an immunocompromising condition given her age and the fact that she has
presented with pneumonia.
 We will get immunoglobulin levels and HIV serology to rule in a immunocompromised state.
 We will obtain sputum Gram stain, culture and sensitivity
 Legionella and pneumococcal urine antigen.
 Looking at the x-ray done 11 days ago, this was a right lower lobe pneumonia and now we
have a middle and upper lobe pneumonia. This speaks to a new process rather than a
continuation of her prior pneumonia.
 In terms of the antibiotic regimen, I think a respiratory fluoroquinolone would have been
 adequate, ciprofloxacin would not cover any of the respiratory flora, maybe this is why she
progressed despite the use of Cipro.
 Respiratory Fluoroquinolones are Moxifloxacin (Avelox) and Levofloxacin (Levaquin)
 However, she has been on steroids and has been on antibiotics.
 Steroids put a patient in a immunocompromised state .
 She is bringing up sputum so we can get a Gram stain, culture and sensitivity to taper the
antibiotic regimen.
Discharge summary
 Hospitalist team was called to admit for failed outpatient treatment for complicated
pneumonia.
 Blood cultures were ordered. She was ruled out for influenza with a nasal swab.
 CT of the chest was ordered.
 CT of the chest without contrast showed right upper lobe and middle lobe pneumonia.
 The pulmonologist who evaluated the patient. His impression was community-acquired
pneumonia
 with adequate outpatient therapy.
 Consult was placed with infectious disease due to the failed outpatient therapy.
 ID doctor continued to make recommendations for antibiotics throughout her stay.
 Her sputum grew normal respiratory flora after 48 hours.
 HIV antibodies came back nonreactive.
 She was found to be positive for IgM immunoglobulin.
 Consult was placed with Hematology/Oncology. He recommended conservative therapy
with the current antibiotics and close monitoring
 The patient was discharged in stable condition.
Electronic copy of the Spectrum
 Please write your email addresses down if you would like
to receive an electronic copy of this Abx spectrum chart
on your email so it can be easily accessed via your phone
or computer.

Contenu connexe

Tendances

A case presentation on pneumonia
A case presentation on pneumoniaA case presentation on pneumonia
A case presentation on pneumoniaPrincy Varghese
 
Community Acquired Pneumonia- Comprehensive Review
Community Acquired Pneumonia- Comprehensive ReviewCommunity Acquired Pneumonia- Comprehensive Review
Community Acquired Pneumonia- Comprehensive Reviewjamal turki
 
Community acquired pneumonia (cap)
Community   acquired pneumonia (cap)Community   acquired pneumonia (cap)
Community acquired pneumonia (cap)Ngọc Anh Lương
 
Management Of Community Acquired Pneumonia
Management  Of Community Acquired PneumoniaManagement  Of Community Acquired Pneumonia
Management Of Community Acquired PneumoniaAshraf ElAdawy
 
Community acquired pneumonia by dr md abdullah saleem
Community acquired pneumonia by dr md abdullah saleemCommunity acquired pneumonia by dr md abdullah saleem
Community acquired pneumonia by dr md abdullah saleemsaleem051
 
Pediatric Community Acquired Pneumonia
Pediatric Community Acquired PneumoniaPediatric Community Acquired Pneumonia
Pediatric Community Acquired PneumoniaDJ CrissCross
 
Pneumocystis PNa and HyperCa
Pneumocystis PNa and HyperCaPneumocystis PNa and HyperCa
Pneumocystis PNa and HyperCaBrian Locke
 
Community acquired pneumonia workshop
Community acquired pneumonia workshopCommunity acquired pneumonia workshop
Community acquired pneumonia workshopHiba Ashibany
 
Pulmonary Board Review 2008
Pulmonary Board Review 2008Pulmonary Board Review 2008
Pulmonary Board Review 2008jcm MD
 
COMMUNITY ACQUIRED PNEUMONIA
COMMUNITY ACQUIRED PNEUMONIACOMMUNITY ACQUIRED PNEUMONIA
COMMUNITY ACQUIRED PNEUMONIAmandar haval
 
Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia NITISH SHAH
 
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...WAidid
 
Childhood Pneumonia 2017, BSMMU, Bangladesh.
Childhood Pneumonia 2017, BSMMU, Bangladesh.Childhood Pneumonia 2017, BSMMU, Bangladesh.
Childhood Pneumonia 2017, BSMMU, Bangladesh.abdullahel amaan
 
Community- Acquired Pneumonia
Community- Acquired PneumoniaCommunity- Acquired Pneumonia
Community- Acquired PneumoniaSun Yai-Cheng
 

Tendances (18)

A case presentation on pneumonia
A case presentation on pneumoniaA case presentation on pneumonia
A case presentation on pneumonia
 
Pediatric pneumonia
Pediatric pneumoniaPediatric pneumonia
Pediatric pneumonia
 
Community Acquired Pneumonia- Comprehensive Review
Community Acquired Pneumonia- Comprehensive ReviewCommunity Acquired Pneumonia- Comprehensive Review
Community Acquired Pneumonia- Comprehensive Review
 
Community acquired pneumonia (cap)
Community   acquired pneumonia (cap)Community   acquired pneumonia (cap)
Community acquired pneumonia (cap)
 
Management Of Community Acquired Pneumonia
Management  Of Community Acquired PneumoniaManagement  Of Community Acquired Pneumonia
Management Of Community Acquired Pneumonia
 
Community acquired pneumonia by dr md abdullah saleem
Community acquired pneumonia by dr md abdullah saleemCommunity acquired pneumonia by dr md abdullah saleem
Community acquired pneumonia by dr md abdullah saleem
 
Pediatric Community Acquired Pneumonia
Pediatric Community Acquired PneumoniaPediatric Community Acquired Pneumonia
Pediatric Community Acquired Pneumonia
 
Pneumocystis PNa and HyperCa
Pneumocystis PNa and HyperCaPneumocystis PNa and HyperCa
Pneumocystis PNa and HyperCa
 
Community acquired pneumonia workshop
Community acquired pneumonia workshopCommunity acquired pneumonia workshop
Community acquired pneumonia workshop
 
Pulmonary Board Review 2008
Pulmonary Board Review 2008Pulmonary Board Review 2008
Pulmonary Board Review 2008
 
COMMUNITY ACQUIRED PNEUMONIA
COMMUNITY ACQUIRED PNEUMONIACOMMUNITY ACQUIRED PNEUMONIA
COMMUNITY ACQUIRED PNEUMONIA
 
Update in CAP 2019
Update in CAP 2019Update in CAP 2019
Update in CAP 2019
 
Acute bronchiolitis
Acute  bronchiolitisAcute  bronchiolitis
Acute bronchiolitis
 
Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia
 
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
 
Fever in children
Fever in childrenFever in children
Fever in children
 
Childhood Pneumonia 2017, BSMMU, Bangladesh.
Childhood Pneumonia 2017, BSMMU, Bangladesh.Childhood Pneumonia 2017, BSMMU, Bangladesh.
Childhood Pneumonia 2017, BSMMU, Bangladesh.
 
Community- Acquired Pneumonia
Community- Acquired PneumoniaCommunity- Acquired Pneumonia
Community- Acquired Pneumonia
 

Similaire à April 24th ppt

IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...iosrphr_editor
 
Sepsis in Post Transplant Patients
Sepsis in Post Transplant PatientsSepsis in Post Transplant Patients
Sepsis in Post Transplant PatientsHina Lodhi
 
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...Riaz Rahman
 
MCQs & Case Discussion- 2
MCQs & Case Discussion- 2MCQs & Case Discussion- 2
MCQs & Case Discussion- 2Suprakash Das
 
Mksap13 pulmonary medicine-and_critical_care
Mksap13 pulmonary medicine-and_critical_careMksap13 pulmonary medicine-and_critical_care
Mksap13 pulmonary medicine-and_critical_caresarfaraz ahmed
 
Interactive case presentation
Interactive case presentationInteractive case presentation
Interactive case presentationGamal Agmy
 
New Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxNew Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxMaheen Fatima
 
Case history of amiodarone induced pulmonary toxicity
Case history of amiodarone induced pulmonary toxicityCase history of amiodarone induced pulmonary toxicity
Case history of amiodarone induced pulmonary toxicitymohammed sediq
 
Drs. Olson’s and Jackson’s CMC Pediatric X-Ray Mastery: May Cases
Drs. Olson’s and Jackson’s CMC Pediatric X-Ray Mastery: May CasesDrs. Olson’s and Jackson’s CMC Pediatric X-Ray Mastery: May Cases
Drs. Olson’s and Jackson’s CMC Pediatric X-Ray Mastery: May CasesSean M. Fox
 
2 severe respiratory infections in the icu
2 severe respiratory infections in the icu2 severe respiratory infections in the icu
2 severe respiratory infections in the icuIslam Ibrahim
 
2 severe respiratory infections in the icu
2 severe respiratory infections in the icu2 severe respiratory infections in the icu
2 severe respiratory infections in the icuIslam Ibrahim
 
Community acquired pneumonia
Community acquired pneumoniaCommunity acquired pneumonia
Community acquired pneumoniaHarsha Vardhan
 

Similaire à April 24th ppt (20)

IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
 
Sepsis in Post Transplant Patients
Sepsis in Post Transplant PatientsSepsis in Post Transplant Patients
Sepsis in Post Transplant Patients
 
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...
Diagnosis & Mangement of Community-Acquired Pneumonia, Hospital Acquired Pneu...
 
Case discussion
Case discussionCase discussion
Case discussion
 
MCQs & Case Discussion- 2
MCQs & Case Discussion- 2MCQs & Case Discussion- 2
MCQs & Case Discussion- 2
 
HIV IN THE ICU
HIV IN THE ICUHIV IN THE ICU
HIV IN THE ICU
 
Monstering Humans.Ppt 2003
Monstering Humans.Ppt 2003Monstering Humans.Ppt 2003
Monstering Humans.Ppt 2003
 
Mksap13 pulmonary medicine-and_critical_care
Mksap13 pulmonary medicine-and_critical_careMksap13 pulmonary medicine-and_critical_care
Mksap13 pulmonary medicine-and_critical_care
 
Interactive case presentation
Interactive case presentationInteractive case presentation
Interactive case presentation
 
New Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxNew Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptx
 
Case history of amiodarone induced pulmonary toxicity
Case history of amiodarone induced pulmonary toxicityCase history of amiodarone induced pulmonary toxicity
Case history of amiodarone induced pulmonary toxicity
 
Drs. Olson’s and Jackson’s CMC Pediatric X-Ray Mastery: May Cases
Drs. Olson’s and Jackson’s CMC Pediatric X-Ray Mastery: May CasesDrs. Olson’s and Jackson’s CMC Pediatric X-Ray Mastery: May Cases
Drs. Olson’s and Jackson’s CMC Pediatric X-Ray Mastery: May Cases
 
Fever Of Unknown Origin
Fever Of Unknown OriginFever Of Unknown Origin
Fever Of Unknown Origin
 
Introduction
IntroductionIntroduction
Introduction
 
2 severe respiratory infections in the icu
2 severe respiratory infections in the icu2 severe respiratory infections in the icu
2 severe respiratory infections in the icu
 
2 severe respiratory infections in the icu
2 severe respiratory infections in the icu2 severe respiratory infections in the icu
2 severe respiratory infections in the icu
 
Diphtheria
DiphtheriaDiphtheria
Diphtheria
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Persistant pneumonia
Persistant pneumoniaPersistant pneumonia
Persistant pneumonia
 
Community acquired pneumonia
Community acquired pneumoniaCommunity acquired pneumonia
Community acquired pneumonia
 

Dernier

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Dr. Dheeraj Kumar
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfHongBiThi1
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 

Dernier (20)

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfSGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdf
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 

April 24th ppt

  • 1. Shashank Sridhara University of Florida College of Pharmacy Doctor of Pharmacy Candidate 2014
  • 2. Our Patient  33 y.o Caucasian Female  PMH- Type 2 Diabetes* & Hypertension  S Hx- Stopped smoking a few months ago and no EtOH use  F Hx- Noncontributory  CC- Pulmonary Sx, Productive cough, SOB, fever and subjective chills.  2-3 weeks before being admitted Pt’s mother had a Sinus infection or a URTI.  2 weeks prior Pt was in ED and was treated for Pneumonia.  Patient received Amoxicillin as an inpatient and completed a course of Ciprofloxacin along with steroids as an outpatient.  Pt remains symptomatic and is now admitted
  • 3. Our Patient Physical examination  VITAL SIGNS: She did have a temperature of 100.1, currently afebrile.  She is 93% on room air.  HEENT: Oral cavity clear.  CHEST: Clear to auscultation bilaterally.  CARDIOVASCULAR: S1 and S2 heard. Regular rate and rhythm.  ABDOMEN: Soft, nontender.  EXTREMITIES: No edema.  MUSCULOSKELETAL: No joint swelling.  SKIN: No obvious rashes.
  • 4. Our Patient Lab Data 1  Her D-dimer (to rule out thrombosis) was negative at 0.47.  Na is 132 (135 - 147 mEq/L )  K is 4.1 (3.5 - 5.2 mEq/L )  BUN of 10 ( 7 - 20 mg/dl)  Creatinine- 0.6 (0.5 - 1.4 mg/dl)  Lactic acid is 2.8 (0.7 - 2.1 meq/L)  White count is 9 (4.5-10 x10^3)  Hematocrit is 42.9 (41-50%)  Platelets of 312,000. (100,000 to 450,000)  Her chest x-ray shows a worsening right-sided and also now left- sided infiltrate.  A CT scan has been ordered  Blood cultures are pending
  • 5. Patient Meds Pre Admission •Glipizide 5 mg BID •Metoprolol 100mg BID •Lisinopril/Hctz 40/12.5 BID •Clonidine 0.1mg BID •Metformin 500mg BID •Ibuprofen 800mg PRN/TID
  • 6. Potential Interactions with Abx & Home meds  Ran an interaction check with Home meds & Possible Tx options (Levaquin, Avelox, Cipro, Amoxicillin and Azithromycin)  Many PD and PK interactions  Most of the interactions were minor and none of them were major or contraindicated.  Increased effects of metformin and glipizide were the most concerning of the minor interactions.  Azithromycin and moxifloxacin both increase the QTc interval. Significant - Monitor Closely.
  • 7. CAP- community acquired pneumonia  Common Typical Pathogens  S.pneumoniae  H.influenzaei  Viral  Oral anaerobes (Aspiration)
  • 9. Complicated (Atypical) Pneumonia  Atypical pneumonia aka walking pneumonia  Not caused by traditional pathogens  Clinical presentation contrasts typical  These atypical organisms include special bacteria, viruses, fungi, and protozoa  Usually will not respond to Beta Lactams and Sulfonamide class of Abx
  • 10. Complicated (Atypical) Pneumonia Signs/Sx  No signs and symptoms of lobar consolidation,[ meaning that the infection is restricted to small areas, rather than involving a whole lobe. As the disease progresses, however, the look can tend to lobar pneumonia (noted in our patient)  Absence of leukocytosis (noted in our patient)  Moderate amount of sputum, or no sputum at all (i.e. non- productive).  Lack of alveolar exudate.  Despite general Sx and problems with the URT (such as high fever, headache, a dry irritating cough followed later by a productive cough with radiographs showing consolidation), there are in general few physical signs. The patient looks better than the symptoms suggest.
  • 11. Complicated Pneumonia Pathogens  Most common causative organisms are (often intracellular living) bacteria.  Chlamydophilia Pnemoniae  Legionella Pneumphila  Mycoplasma Pneumoniae  Viral causes  Respiratory Synctial Virus(RSV),  Influenza A and B
  • 12. Diagnosis  Chest X-rays are gold standard for diagnosis.  They show a pulmonary infection before physical signs of atypical pneumonia are observable at all.  Infiltration commonly occurs near the where the bronchus begins and tends to be more bilateral .The process most often involves the lower lobe, but may affect any lobe or combination of lobes.
  • 13. Chest X-Rays of Atypical vs Typical Strep (typical) is more unilateralAtypical is more bilateral
  • 15. Assessment and Plan 1 1. Complicated pneumonia potentially atypical. We will admit for Brevard  Pulmonary consultation. We will check blood cultures and other cultures.  Zosyn and Azithromycin initiated.  Rule out for influenza with nasal swab.  Check a CT scan just to rule out any more complicated infection. 2. Diabetes. Continue her on sliding scale insulin and carb-controlleddiet. 3. Hypertension. Continue on her home medications and follow her course expectantly.
  • 16. Global Rph Empiric Tx Abx site http://www.globalrph.com/antibiotic.htm
  • 17. Lab data 2  White count is 9.79  Platelets 275,000  Neutrophils 64.1.  Blood cultures are negative so far.  Her chest x-ray does show pneumonia of the right lung, which apparently has worsened from previous x-ray.  She did have a CT chest, which showed right upper and middle lobe pneumonia 2 days ago. Her last x-ray was 13 days ago at that point, she had right lower lobe infiltrate and the current CT chest, actually showing right upper and middle lobe infiltrates.
  • 18. Assessment and plan 2  This is a very young woman who has now presented with pneumonia.  Concerned about an immunocompromising condition given her age and the fact that she has presented with pneumonia.  We will get immunoglobulin levels and HIV serology to rule in a immunocompromised state.  We will obtain sputum Gram stain, culture and sensitivity  Legionella and pneumococcal urine antigen.  Looking at the x-ray done 11 days ago, this was a right lower lobe pneumonia and now we have a middle and upper lobe pneumonia. This speaks to a new process rather than a continuation of her prior pneumonia.  In terms of the antibiotic regimen, I think a respiratory fluoroquinolone would have been  adequate, ciprofloxacin would not cover any of the respiratory flora, maybe this is why she progressed despite the use of Cipro.  Respiratory Fluoroquinolones are Moxifloxacin (Avelox) and Levofloxacin (Levaquin)  However, she has been on steroids and has been on antibiotics.  Steroids put a patient in a immunocompromised state .  She is bringing up sputum so we can get a Gram stain, culture and sensitivity to taper the antibiotic regimen.
  • 19. Discharge summary  Hospitalist team was called to admit for failed outpatient treatment for complicated pneumonia.  Blood cultures were ordered. She was ruled out for influenza with a nasal swab.  CT of the chest was ordered.  CT of the chest without contrast showed right upper lobe and middle lobe pneumonia.  The pulmonologist who evaluated the patient. His impression was community-acquired pneumonia  with adequate outpatient therapy.  Consult was placed with infectious disease due to the failed outpatient therapy.  ID doctor continued to make recommendations for antibiotics throughout her stay.  Her sputum grew normal respiratory flora after 48 hours.  HIV antibodies came back nonreactive.  She was found to be positive for IgM immunoglobulin.  Consult was placed with Hematology/Oncology. He recommended conservative therapy with the current antibiotics and close monitoring  The patient was discharged in stable condition.
  • 20. Electronic copy of the Spectrum  Please write your email addresses down if you would like to receive an electronic copy of this Abx spectrum chart on your email so it can be easily accessed via your phone or computer.

Notes de l'éditeur

  1. It is impt to note that in patients with comorbid conditions such as diabetes infections tend to be more complicated and more difficult to treat.The focus of this presentation will be mostly on the topic of Infectious disease.
  2. Talk about interactions here- run an interaction checker and screen shot that shit with all the potential interactions w/ Abx.
  3. Possible pathogensAnd treatment optionsMoraxellacatarrhalis not added here is very rare and usually not seen in patients w/ pneumoniaStrep Pneumo most common type of typical bacteria pneumo
  4. Need to go over the basics, Signs & Sx
  5. Alveolar exudate- The surrounding alveolar walls have capillaries that are dilated and filled with RBC's. Such an exudative process is typical for bacterial infection. This exudate gives rise to the productive cough of purulent yellow sputum seen with bacterial pneumonias.
  6. If you look at your 4 page Abx spectrum that I have printed out for you, it will list the most common atypical pathogens.Mycoplasma is a type of bacteria without a cell wallMycoplasma is found more often in younger than in older peopleOlder people are more often infected by Legionella.
  7. Describe what’s on it and go through some examplesFor example- we can start to look at some treatment options for Atypical pathogens….on page 4 it should show you what they are and we can now choose some Abx based off of this chart.
  8. Walk them through this website….different disease states and treatment options.
  9. Indicating a progress of the disease.
  10. IgM antibodies appear early in the course of an infection and usually reappear, to a lesser extent, after further exposure. IgM antibodies do not pass across the human placenta.These two biological properties of IgM make it useful in the diagnosis of infectious diseases. Demonstrating IgM antibodies in a patient's serum indicates recent infectionNeed to find out what her final outpatient medications r still
  11. Spectrum double sided x 4Screen shots of the website (screen with dx state and detailed dose screen x4) Find out her final plan and outpatient meds that she was sent home on.How long was she in hospital for total?